If the government does not incentivize drugmakers to develop new antibiotics, the World Health Organization (WHO) fears that drug-resistant infections could kill upwards of 10 million people annually by 2050, according to Becker’s Hospital Review.

About 700,000 people die every year due to ineffective antibiotics and most antibiotics that are being developed aren’t targeting the most dangerous, drug-resistant infections. Currently, drugmakers are less inclined to take the initiative to create new antibiotics due to the high costs associated with developing them, and the fact that physicians prefer older, cheaper ones.

According to Sarah Paulin, technical officer of antimicrobial resistance and innovation at the WHO, “We still have a window of opportunity, but we need to ensure there is investment now so we don’t run out of options for future generations.” The New York Times noted that congress is considering a bill that would “support the market for antibiotics but it has not advanced despite bipartisan support”.

Global antibiotic consumption rates have increased by 46 percent since 2000

According to a new study recently shared by...

Hospital acquired drug resistant infections, deaths rose 15% from 2019-20: CDC

Hospital-acquired drug-resistant infections,...

US hospitals lost $22.3B delaying elective surgeries, study estimates

As a result of the pandemic, a study shared by...

Principal causes for hospital readmission identified

A group of physicians in Canada examined a...

New antibiotic packs a punch against bacterial resistance

Scientists at The Scripps Research Institute...

Nuestro reloj biológico juega un papel crucial en la curación de la cirugía.

Según un estudio compartido por ScienceDaily,...

ISASS 2021 – The International Society for the Advancement of Spine Surgery

2021-05-13 - 2021-05-15 / English / Congress...

¿Qué es la osteomielitis?

El Dr. Pablo S. Corona...

Distribuidor exclusivo.

0